| Rodney Zane Jarrell, DO | |
|
1710 Harper Rd, Beckley, WV 25801-3357 | |
| (304) 256-4181 | |
| Not Available |
| Full Name | Rodney Zane Jarrell |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1710 Harper Rd, Beckley, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174569800 | NPI | - | NPPES |
| 001759555 | Other | WV | BCBS |
| 3810003689 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2004 (West Virginia) | Primary |
| Entity Name | Health Care Alliance, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730128760 PECOS PAC ID: 5799689105 Enrollment ID: O20050816000292 |
News Archive
Genetics researchers have unveiled a powerful new resource for scientists and health providers studying human illnesses - a reference standard of deletions and duplications of DNA found in the human genome. Drawn from over 2,000 healthy persons, the study provides one of the deepest and broadest sets of copy number variations (CNVs) available to date, along with a new research tool for diagnosing and identifying genetic problems in patients.
An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
Maintaining a healthy weight and lifestyle, to include physical exercise and leisure and social activities, prolongs life even among the elderly, show results of a Swedish study involving individuals aged 75 years and over.
Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rodney Zane Jarrell, DO 107 Honda Dr, Beckley, WV 25801-2347 Ph: (304) 923-6746 | Rodney Zane Jarrell, DO 1710 Harper Rd, Beckley, WV 25801-3357 Ph: (304) 256-4181 |
News Archive
Genetics researchers have unveiled a powerful new resource for scientists and health providers studying human illnesses - a reference standard of deletions and duplications of DNA found in the human genome. Drawn from over 2,000 healthy persons, the study provides one of the deepest and broadest sets of copy number variations (CNVs) available to date, along with a new research tool for diagnosing and identifying genetic problems in patients.
An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
Maintaining a healthy weight and lifestyle, to include physical exercise and leisure and social activities, prolongs life even among the elderly, show results of a Swedish study involving individuals aged 75 years and over.
Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
› Verified 2 days ago
Divya S. Rajan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1832 Harper Rd, Beckley, WV 25801 Phone: 681-207-7129 Fax: 681-207-7132 | |
Dr. Luis Alejandro Asencio Magdaleno, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 Harper Rd, Second Floor, Suite G, Beckley, WV 25801 Phone: 304-461-3922 | |
Dr. Seema Anand, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 | |
Thair A Barghouthi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 304 Carriage Dr, Beckley, WV 25801 Phone: 304-254-0892 Fax: 304-254-0893 | |
Dr. Hafiz Imran Iqbal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 242 George St, Beckley, WV 25801 Phone: 304-255-7878 Fax: 304-256-0060 | |
Norma J Mullins, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3771 Robert C Byrd Drive, Beckley, WV 25801 Phone: 304-255-5710 Fax: 304-255-5702 | |
Jose Jorge Gordinho, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2962 Robert C. Byrd Drive, Beckley, WV 25801 Phone: 304-254-9022 Fax: 304-254-9024 |